News &amp; Updates

Long-term care facility (LTCF) residents aged ≥65 years appeared to be protected from COVID-19 4–7 weeks after receiving their first dose of the ChAdOx1 nCoV-19 or BNT162b2 vaccine, according to a study presented at ECCMID 2021.

First dose of ChAdOx1, BNT162b2 vaccines may be protective in LTCF residents after 4 weeks

Migraine tied to more COVID-19 symptoms

People with migraine were more likely to report having COVID-19 symptoms, yet less likely to utilize healthcare resources compared with infected individuals without migraine, according to a study presented at the 2021 AHS Annual Meeting.

Migraine tied to more COVID-19 symptoms

MRSA acquisition in hospitals tied to ward characteristics

In hospitals, the risk of acquiring methicillin-resistant Staphylococcus aureus (MRSA) is high in wards that receive a high number of MRSA-colonized patients coming from other wards, according to a Singapore study.

MRSA acquisition in hospitals tied to ward characteristics

T-cell responses to BNT162b2 vaccine not weakened by methotrexate

Patients with psoriasis taking the immunosuppressant methotrexate had low antibody responses to SARS-CoV-2 after receiving the first dose of Pfizer-BioNTech’s BNT162b2 vaccine but had shown T-cell responses, according to a study that was the first to look at T-cell responses in patients taking methotrexate.

T-cell responses to BNT162b2 vaccine not weakened by methotrexate

Prenatal household air pollution exposure poses infection risk in infants

25 Jul 2021

Exposure to household air pollution during pregnancy may put babies at risk of developing pneumonia, including severe infection, in their first year of life, a study has found.

Prenatal household air pollution exposure poses infection risk in infants

25 Jul 2021

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Treatment for chronic hepatitis B virus (CHB) infection results in significant reductions in risk of cirrhosis among noncirrhotic CHB patients, according to a study.

Antiviral therapy lowers cirrhosis risk in noncirrhotic HBV patients

Sex, gender overlooked in COVID-19 research

Most studies and clinical trials regarding the novel coronavirus disease (COVID-19) fail to consider sex and gender as important variables affecting outcomes, a recent study has found.

Sex, gender overlooked in COVID-19 research

Recombinant zoster vaccine cuts infection risk in older IBD patients

Older inflammatory bowel disease (IBD) patients who receive the recombinant zoster vaccine are less likely to develop herpes zoster infection, as shown in a study.

Recombinant zoster vaccine cuts infection risk in older IBD patients